Kevin Sidow - 22 Jul 2025 Form 4 Insider Report for CARLSMED, INC.

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
24 Jul 2025, 20:32:18 UTC
Next SEC filing
22 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Leonard Greenstein, as attorney-in-fact for Kevin Sidow

Key filing fact

Kevin Sidow filed Form 4 for CARLSMED, INC. on 24 Jul 2025.

Key facts

  • This page summarizes Kevin Sidow's Form 4 filing for CARLSMED, INC..
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 24 Jul 2025, 20:32.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: +$199,995.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001416947 Primary reporting owner

Sidow Kevin

Relationship
Director
Address
C/O CARLSMED, INC., 1800 ASTON AVE., SUITE 100, CARLSBAD
Signature
/s/ Leonard Greenstein, as attorney-in-fact for Kevin Sidow
Signature date
24 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CARL transaction

Common Stock

Award

Transaction value
$0
Shares
+17,333
Change %
Price
$0.000000
Shares after
17,333
Date
22 Jul 2025
Ownership
Direct
Footnotes
F1, F2
CARL transaction

Common Stock

Options Exercise

Transaction value
Shares
+28,900
Change %
Price
Shares after
28,900
Date
24 Jul 2025
Ownership
Direct
Footnotes
F3
CARL transaction

Common Stock

Purchase

Transaction value
$199,995
Shares
+13,333
Change %
+29%
Price
$15.00
Shares after
59,566
Date
24 Jul 2025
Ownership
Direct
Footnotes
F4, F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CARL transaction Derivative

Series B Preferred Stock

Conversion of derivative security

Transaction value
Shares
-28,900
Change %
-100%
Price
Shares after
0
Date
24 Jul 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
28,900
Exercise price
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Constitute an award of restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in equal annual installments over three years.

Footnote F2

Includes 17,333 unvested restricted stock units convertible into approximately 17,333 shares of the Issuer's common stock.

Footnote F3

These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date.

Footnote F4

Includes 13,333 shares of the Issuer's common stock purchased by the Reporting Person in the Issuer's initial public offering at the public offering price of $15.00 per share. The purchase was made directly from the underwriters in connection with the offering.

Footnote F5

Includes (i) 17,333 unvested RSUs convertible into approximately 17,333 shares of the Issuer's common stock, (ii) 28,900 shares of common stock issued to Reporting Person upon the conversion of outstanding preferred stock on a 1-to-1 basis, immediately prior to the closing of the Issuer's public offering, and (iii) 13,333 shares of the Issuer's common stock purchased by the Reporting Person in the Issuer's initial public offering at the public offering price of $15.00 per share.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .